Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs
about
Chronic immune activation and inflammation as the cause of malignancy5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissueLipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancerRegular use of aspirin and pancreatic cancer risk.Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCsMolecular Targeted Intervention for Pancreatic CancerCyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during TherapyCell proliferation depends on mitochondrial Ca2+ uptake: inhibition by salicylateNon-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44The anti-tumor effect of HDAC inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins.Effect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells.Screening for novel protein targets of indomethacin in HCT116 human colon cancer cells using proteomicsGrowth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells.Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysisNon-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.Inflammation to cancer: The molecular biology in the pancreas (Review).Phenotype and genotype of pancreatic cancer cell linesRNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells.Case-control study of aspirin use and risk of pancreatic cancer.Targeted therapies for pancreatic cancer.Biological approaches to therapy of pancreatic cancer.Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.Chemoprevention strategies for pancreatic cancerEpstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1Immune response in thyroid cancer: widening the boundaries.COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis.Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasionThe Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic virusesCyclooxygenase-2 expression in hamster and human pancreatic neoplasiaUrinary prostaglandin E2 metabolite and pancreatic cancer risk: case-control study in urban ShanghaiInhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinoma.3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesisPreparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth.Oncolytic virotherapy for pancreatic cancer.Defeating cancer with antidepressants.Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner.
P2860
Q24648532-70E87153-A92A-47D7-9E83-3D9470F3D0C8Q24685466-8FEDECED-1DF5-4855-B655-D05BA38E3629Q24800010-447AA562-4500-42D0-B83A-E39025D5A11CQ24801805-181A9F17-4CA1-474F-A547-8DB6266B7E2AQ24812877-CDF8E107-1568-46C7-A6B8-DC4AE5BEE2A0Q26798453-F2E2A217-CBB4-4905-BE93-F3CEEE19790DQ28073252-C9DE7AAD-E9E4-4743-85A7-01DC38F7B1F5Q28193861-E35728FF-7CA9-45E9-808F-897DDD95FDF0Q28363575-C56AD874-2CAA-4475-A2D6-0BB13C33FAD9Q28533258-9188EAA6-8DBC-4F3C-A8BF-C215BDEE58E7Q30494961-E6D20C75-F05C-4DFA-9880-6ACA62AACABBQ31066911-ED751EE1-E4C9-4113-8119-036E5920132BQ31142615-2524EC34-A1FA-4F64-A711-727012996F04Q33183406-20C04DEB-4953-4F42-9B9E-8DC7F8F5C06DQ33538894-96815F17-7121-4089-AEC8-50BF6ED2B4EAQ33555216-DB52572C-8A19-4F3A-9804-07672FE0F99EQ33664095-08DB4FDE-1B96-44F5-B8E1-44D02616655BQ33727657-A729D379-474B-478F-ABDC-C91A1697240DQ33814471-F19C241C-D682-4F9C-A626-CCCCB34ED883Q33828424-CB788CF8-DCAD-4C2B-AA5B-C40AB53B4B28Q33881059-1FC1605C-ED0E-4AF3-A562-A6B6C0C567FCQ33899923-32A0BA9C-F670-4E08-BD32-AA8469FC915CQ33899938-57A597D3-2301-4ADE-9CE5-9DB99A7F8143Q34067846-C752F0DF-95BC-47E0-A551-3AF054B3E384Q34082960-3FDC3DF9-77FE-4937-9747-FD888B3E4160Q34302223-2AEF3282-22A6-4210-8038-A8E36F728E1DQ34310495-3C4D5A33-57EB-4680-A9E9-878741EBD723Q34502422-DBCCEF1C-FC39-4EDD-BEC1-7E225B58E4ECQ34646962-9CCBD2E8-1F71-4CAE-94CB-6F65A652A61DQ34690409-96E9325C-2336-4B63-9FCC-4C431541871AQ34901718-59D67DB0-8A5E-422F-B530-C50FAD66B6FCQ35082208-EB06004D-34F7-42A1-ABDC-BEE4AE1548DEQ35094999-DB147B73-5788-41F9-B929-90388EA97990Q35184289-692919DD-277B-467B-AFB5-CA6B7A16A333Q35541678-F141C423-5D9C-485F-AF5E-EEA455D4BA6CQ35556908-BE505177-B087-4F8A-B9DD-3A5278A7E904Q35565564-F9C63483-2BAD-47CF-97FE-BE3EBAEEC355Q35590996-4961BCBB-C42D-490E-AA48-A5994E8729C7Q35602233-38C7855F-9A50-4C52-9CC8-995208A0EBABQ35654212-395ABD39-AE83-4D91-AE23-518DB9057DD9
P2860
Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Increased cyclooxygenase-2 exp ...... roidal anti-inflammatory drugs
@ast
Increased cyclooxygenase-2 exp ...... roidal anti-inflammatory drugs
@en
Increased cyclooxygenase-2 exp ...... roidal anti-inflammatory drugs
@nl
type
label
Increased cyclooxygenase-2 exp ...... roidal anti-inflammatory drugs
@ast
Increased cyclooxygenase-2 exp ...... roidal anti-inflammatory drugs
@en
Increased cyclooxygenase-2 exp ...... roidal anti-inflammatory drugs
@nl
prefLabel
Increased cyclooxygenase-2 exp ...... roidal anti-inflammatory drugs
@ast
Increased cyclooxygenase-2 exp ...... roidal anti-inflammatory drugs
@en
Increased cyclooxygenase-2 exp ...... roidal anti-inflammatory drugs
@nl
P2093
P3181
P1433
P1476
Increased cyclooxygenase-2 exp ...... roidal anti-inflammatory drugs
@en
P2093
Frazier ML
Lemoine MG
Sinicrope FA
Sitja-Arnau M
P304
P3181
P407
P577
1999-09-01T00:00:00Z